Related Experiment Video
Updated: Aug 5, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH
P Burman1, E M Ritzén, A C Lindgren
1Pharmacia Corporation, SE-112 87 Stockholm, Sweden. pia.burman@eu.pnu.com
Insights
Prader-Willi syndrome, a genetic disorder, is linked to growth hormone (GH) deficiency. GH replacement therapy shows promise for improving growth and body composition in affected children.
Area of Science:
- Endocrinology
- Genetics
- Pediatrics
Background:
- Prader-Willi syndrome (PWS) is a rare genetic disorder affecting 1 in 10,000-16,000 infants.
- Key features include short stature, hypotonia, developmental delay, behavioral issues, and hyperphagia leading to obesity.
- PWS is often associated with hypothalamic-pituitary dysfunction, specifically growth hormone (GH) deficiency and hypogonadotropic hypogonadism.
Purpose of the Study:
- To evaluate the efficacy and benefits of growth hormone (GH) replacement therapy in children with Prader-Willi syndrome.
- To explore the potential role of sex hormone replacement therapy in managing PWS.
Main Methods:
- Review of clinical trials evaluating GH replacement therapy in children with PWS.
- Analysis of existing data on sex hormone replacement therapy in PWS patients.
Main Results:
- GH treatment demonstrated encouraging results, including improved linear growth and increased lean body mass.
- GH therapy also showed potential benefits in reducing fat mass, improving respiratory function, and enhancing physical activity.
- Limited data exist on the efficacy and long-term benefits of sex hormone replacement therapy.
Conclusions:
- Prader-Willi syndrome is a significant condition characterized by GH deficiency and hypogonadism.
- Active treatment of these endocrine abnormalities, particularly GH replacement, is likely to benefit affected individuals.
- Further research is needed to establish the long-term benefits of GH therapy and clarify the role of sex hormone replacement.
Abstract:
Prader-Willi syndrome is a genetic disorder occurring in 1 in 10,000-16,000 live-born infants. In the general population, approximately 60 people in every 1,000,000 are affected. The condition is characterized by short stature, low lean body mass, muscular hypotonia, mental retardation, behavioral abnormalities, dysmorphic features, and excessive appetite with progressive obesity. Furthermore, morbidity and mortality are high, probably as a result of gross obesity. Most patients have reduced GH secretory capacity and hypogonadotropic hypogonadism, suggesting hypothalamic-pituitary dysfunction. Replacement of GH and/or sex hormones may therefore be beneficial in Prader-Willi syndrome, and several clinical trials have now evaluated GH replacement therapy in affected children. Results of GH treatment have been encouraging: improved growth, increased lean body mass, and reduced fat mass. There was also some evidence of improvements in respiratory function and physical activity. The long-term benefits of GH treatment are, however, still to be established. Similarly, the role of sex hormone replacement therapy needs to be clarified as few data exist on its efficacy and potential benefits. In summary, Prader-Willi syndrome is a disabling condition associated with GH deficiency and hypogonadism. More active treatment of these endocrine disorders is likely to benefit affected individuals.
Related Concept Videos
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hypoglycemia and Glucagon
The Endocrine System
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Hypothyroidism II: Pathophysiology

